[Possible effect of N-Acetyl-L-cysteine on Aβ(25-35)-induced tau hyperphosphorylation].
Tianwen Huang, raoli He, Meng Zhou, Jing Zhang, Zhiying Lin, Qinyong Ye, Xiaochun Chen
Abstract
Tianwen Huang, raoli He, Meng Zhou, Jing Zhang, Zhiying Lin, Qinyong Ye, Xiaochun Chen
Abstract
OBJECTIVE: To investigate the possible effect and mechanism of N-Acetyl-L-cysteine (NAC) on fibrillar Aβ(25-35)-induced tau hyperphosphorylation. METHODS: The phosphorylation of tau was induced by Aβ(25-35) in primary cortical neuron. Neurons were incubated in the absent or present Aβ(25-35), or pre-incubated NAC then co-incubated in Aβ. The measurement of ROS was performed on a microplate fluorometer. The proteins of p35/p25, cdk5, pT205 and pS404 were detected by Western blot. RESULTS: In Aβ treated group, the ROS, pT205 and pS404 level were obviously higher than that in non-treated with Aβ group for 12 h (t=-6.35, P<0.05; t=-5, P<0.05; t=-4.57, P<0.05). However, in neurons pre-incubated with (10 mmol/L) NAC and then co-incubated with 20 µmol/L Aβ, the ROS, pT205 and pS404 level were significantly decreased compared with that of Aβ group (t=3.47, P<0.05; t=3.88, P<0.05 and t=3.64, P<0.05); Upon Aβ exposure for 12 h, cortical neurons showed a statistically significant increase in p25 when compared to the control group (t=-6.20, P<0.05). However, pre-treatment with NAC showed a decrease in p25 as compared to neurons treated with Aβ alone for 12 h (t=4.72, P<0.05). CONCLUSION: NAC attenuated the Aβ(25-35)-induced tau hyperphosphorylation through CDK5 pathway.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the possible effect and mechanism of N-Acetyl-L-cysteine (NAC) on fibrillar Aβ(25-35)-induced tau hyperphosphorylation. METHODS: The phosphorylation of tau was induced by Aβ(25-35) in primary cortical neuron. Neurons were incubated in the absent or present Aβ(25-35), or pre-incubated NAC then co-incubated in Aβ. The measurement of ROS was performed on a microplate fluorometer. The proteins of p35/p25, cdk5, pT205 and pS404 were detected by Western blot. RESULTS: In Aβ treated group, the ROS, pT205 and pS404 level were obviously higher than that in non-treated with Aβ group for 12 h (t=-6.35, P<0.05; t=-5, P<0.05; t=-4.57, P<0.05). However, in neurons pre-incubated with (10 mmol/L) NAC and then co-incubated with 20 µmol/L Aβ, the ROS, pT205 and pS404 level were significantly decreased compared with that of Aβ group (t=3.47, P<0.05; t=3.88, P<0.05 and t=3.64, P<0.05); Upon Aβ exposure for 12 h, cortical neurons showed a statistically significant increase in p25 when compared to the control group (t=-6.20, P<0.05). However, pre-treatment with NAC showed a decrease in p25 as compared to neurons treated with Aβ alone for 12 h (t=4.72, P<0.05). CONCLUSION: NAC attenuated the Aβ(25-35)-induced tau hyperphosphorylation through CDK5 pathway.
Key concepts: Hyperphosphorylation, Cyclin-dependent kinase 5, Western blot, Tau protein, Chemistry, Phosphorylation, Molecular biology, Internal medicine